Friday 23 April 2021




Dutch pause J&J vaccine roll-out

The Netherlands will not start using the Leiden-developed Johnson & Johnson coronavirus vaccine until the European Medicines Agency has completed its safety review, health minister Hugo de Jonge said on Wednesday evening. The Netherlands has some 80,000 doses of the single shot vaccine in storage but J&J has asked EU countries not to use them until the research into rare blood clots has been completed. The vaccine was destined for front line healthcare staff and people in living in small... More >




Hospitals face delaying heart, cancer ops

Several hospitals in the Netherlands are being forced to delay heart and cancer surgery because of the shortage of staff, as more beds are taken up by coronavirus patients, the Volkskrant reported on Sunday. The national acute care association said on Friday that it wanted to scale up the number of IC beds by 100 to 1,550. This, hospital chiefs say, will have an impact on the number of staff available for regular care. The paper bases its claim on... More >







Dutch consortium to confront dementia

A public private partnership made up of 30 hospitals, insurance companies, charities and high tech medical equipment maker Philips has been set up to boost the diagnosis and personalised treatment of Alzheimer’s disease. Aboard, as the consortium has been dubbed, will have some €8.8m to spend over the next five years, of which €5m will contributed by the health and economic affairs ministries. The project forms part of the national dementia strategy which was launched last year. Some 300,000 people... More >


EMA to rule on AstraZeneca vaccine

The Amsterdam-based European Medicines Agency will this afternoon say whether its scientists believe there is a link between rare blood clots and the AstraZeneca coronavirus vaccine. A small number of mainly younger women have developed a form of thrombosis after having the vaccine, leading to its use being halted in a number of countries, including the Netherlands. As yet is is unclear if the condition is linked to the vaccine, but on Tuesday the EMA’s head of vaccination strategy Marco... More >